Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Systemic sclerosis: symptomatic treatment].

Bozena Dziankowska-Bartkowiak1, Elzbieta Waszczykowska, Kamila Skretkowicz

  • 1Samodzielna Pracownia Immunodermatologii Katedry i Kliniki Dermatologii i Wenerologii Akademii Medycznej w Łodzi.

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|December 19, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disturbances of circadian profile and blood pressure control in patients with systemic lupus erythematosus without overt heart disease.

Postepy dermatologii i alergologii·2022
Same author

Role and effectiveness of complex and supervised rehabilitation on overall and hand function in systemic sclerosis patients-one-year follow-up study.

Scientific reports·2021
Same author

The influence of tumour necrosis factor α inhibitors treatment - etanercept on serum concentration of biomarkers of inflammation and cartilage turnover in psoriatic arthritis patients.

Postepy dermatologii i alergologii·2021
Same author

Interleukin-18, interleukin-20, and matrix metalloproteinases (MMP-1, MMP-3) as markers of psoriatic arthritis disease severity and their correlations with biomarkers of inflammation and turnover of joint cartilage.

Postepy dermatologii i alergologii·2021
Same author

The Role of Angiogenesis Factors in the Formation of Vascular Changes in Scleroderma by Assessment of the Concentrations of VEGF and sVEGFR2 in Blood Serum and Tear Fluid.

Mediators of inflammation·2020
Same author

Abnormalities of heart rate turbulence and heart rate variability as indicators of increased cardiovascular risk in patients with systemic sclerosis.

Postepy dermatologii i alergologii·2020

Systemic sclerosis is a difficult autoimmune disease causing fibrosis. This paper reviews current and novel treatments targeting its complex pathogenesis and multi-systemic effects.

Area of Science:

  • Rheumatology
  • Immunology
  • Pathophysiology

Context:

  • Systemic sclerosis is an autoimmune connective tissue disease characterized by fibrosis affecting skin and internal organs.
  • Its pathogenesis involves complex interactions of genetic and environmental factors, leading to immune activation, vascular issues, and excessive collagen deposition.

Purpose:

  • To review established and emerging therapies for systemic sclerosis.
  • To provide insights into managing this challenging condition based on its underlying pathogenesis.

Summary:

  • Treatment strategies for systemic sclerosis aim to address immune activation, vascular abnormalities, and fibrosis.
  • Therapies include vasoactive drugs, antifibrotic agents, immunosuppression, and symptomatic relief.

Related Experiment Videos

Impact:

  • Offers a comprehensive overview of systemic sclerosis treatments for clinicians and researchers.
  • Highlights the need for targeted therapies due to the disease's multi-systemic impact on digestive, pulmonary, cardiovascular, neuromuscular, and locomotor systems.